MS drug almost halves hospitalised patients’ risk of severe Covid symptoms

A drug used for multiple sclerosis nearly halves the chance of developing severe coronavirus symptoms in hospitalised patients and may prevent deaths, a new trial has shown. Covid patients at nine hospitals including Southampton General were given an inhaled version of the treatment interferon beta-1a and were twice as likely to recover within 14 days as […]